Rosalind Advisors »

Spdr S&p 500 Etf Tr option shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Spdr S&p 500 Etf Tr option shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Spdr S&p 500 Etf Tr option

Tip: Access up to 7 years of quarterly data

All positions including Spdr S&p 500 Etf Tr option held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spdr S&p 500 Etf Tr option by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $718k 300k 2.39
2025-06-30 $433k 250k 1.73

More positions owned by Rosalind Advisors

Delcath Sys Com New (DCTH)
Cytokinetics Com New (CYTK)
Fennec Pharmaceuticals (FENC)
Verastem Com New (VSTM)
Rezolute Com New (RZLT)
Xeris Pharmaceuticals (XERS)
Savara (SVRA)
Mediwound Shs New (MDWD)
Miragen Therapeutics (VRDN)
Cg Oncology (CGON)
Verona Pharma Sponsored Ads (VRNA)
Ideaya Biosciences (IDYA)
Inspiremd (NSPR)
Eyepoint Pharmaceuticals Com New (EYPT)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Rosalind Advisors

Top funds holding Spdr S&p 500 Etf Tr option

Optiver Holding B.V.
Simplex Trading
IMC-Chicago
Akuna Securities
Jpmorgan Chase & Co
SG Americas Securities
Swan Wealth Advisors
Rule One Partners
Cooper Creek Partners Management
Maven Securities
Rosalind Advisors
Warberg Asset Management
Quattro Financial Advisors
Riposte Capital
Truffle Hound Capital

View all funds holding Spdr S&p 500 Etf Tr option